Waldenstrom Macroglobulinaemia Clinical Trials

11 clinical trials for Waldenstrom Macroglobulinaemia across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• SynKIR-310 for Relapsed/Refractory B-NHL — RECRUITING · PHASE1
• German Lymphoma Alliance registry — RECRUITING
• This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenström's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process — RECRUITING
• Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing — RECRUITING
• Evaluation of Iopofosine I 131 vs. R-CD in WM Patients — NOT_YET_RECRUITING · PHASE3
• Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors — NOT_YET_RECRUITING · NA
• BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases. — NOT_YET_RECRUITING · PHASE4
• Routine care of patients with Waldenstrom's disease treated between 2020 and 2021 in hematology practices in Germany — OTHER
• Treatment and outcome patterns in patients with Waldenström’s Macroglobulinemia (WM): An observational, retrospective chart review across Germany — OTHER
• A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies — COMPLETED · PHASE1
• A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia — COMPLETED · PHASE2

Refine this search